Daniel Griffith Anderson is of Sigilon Therapeutics, Inc.. Currently has a direct ownership of 2.02 Million shares of SGTX, which is worth approximately $0. The most recent transaction as insider was on Jun 02, 2021, when has been sold 200,000 shares (Common Stock) at a price of $10.0 per share, resulting in proceeds of $2,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.02M
0% 3M change
0% 12M change
Total Value Held $0

DANIEL GRIFFITH ANDERSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2021
SELL
Open market or private sale
$2,000,000 $10.0 p/Share
200,000 Reduced 9.0%
2,022,222 Common Stock
DGA

Daniel Griffith Anderson

Cambridge, MA

Track Institutional and Insider Activities on SGTX

Follow Sigilon Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGTX shares.

Notify only if

Insider Trading

Get notified when an Sigilon Therapeutics, Inc. insider buys or sells SGTX shares.

Notify only if

News

Receive news related to Sigilon Therapeutics, Inc.

Track Activities on SGTX